The possibility of treating chronic ITP in adults with monomeric IgG is investigated. A platelet rise was observed in all treated subjects although the height of the peak was quite variable. A platelet count of ≥50 x 109/l was observed in 11 out of 14 patients. Splenectomized subjects responded well to the treatment. The therapeutic effect is in general short-lived. No significant side-effects were observed. Circulating immune complexes appeared or increased after the infusion of high doses of this immunoglobulin.
|Number of pages||4|
|Publication status||Published - 1985|
ASJC Scopus subject areas